Valeant in new deal with Walgreens, will help to lower prices of some drugs
NEW YORK, N.Y. – Valeant Pharmaceuticals has a new distribution deal with Walgreens, sending shares of the beleaguered drug company up sharply before the opening bell.
The company said Tuesday that the agreement will help to lower the prices of its branded prescription-based dermatological and ophthalmological products by 10 per cent. The reduced pricing will apply to the wholesale list prices of the products and be phased in over the next six to nine months. The deal also covers over-the-counter products made by Valeant Pharmaceuticals International Inc.
The deal will allow consumers to get Valeant’s dermatology and ophthalmology products — including Luzu and Zylet — at a lower out-of-pocket cost from more than 8,000 Walgreens U.S. retail pharmacy locations and participating independent retailers.
The 20-year deal takes effect early next year.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
